Show simple item record

dc.contributor.authorDimitri, P.en
dc.contributor.authorHabeb, A. M.en
dc.contributor.authorGurbuz, F.en
dc.contributor.authorMillward, A.en
dc.contributor.authorWallis, S.en
dc.contributor.authorMoussa, K.en
dc.contributor.authorAkcay, T.en
dc.contributor.authorTaha, D.en
dc.contributor.authorHogue, J.en
dc.contributor.authorSlavotinek, A.en
dc.contributor.authorWales, J. K. H.en
dc.contributor.authorShetty, A.en
dc.contributor.authorHawkes, D.en
dc.contributor.authorHattersley, Andrew T.en
dc.contributor.authorEllard, Sianen
dc.contributor.authorDe Franco, Elisaen
dc.identifier.citationExpanding the Clinical Spectrum Associated With GLIS3 Mutations. 2015, 100 (10):E1362-9 J. Clin. Endocrinol. Metab.en
dc.description.abstractGLIS3 (GLI-similar 3) is a member of the GLI-similar zinc finger protein family encoding for a nuclear protein with 5 C2H2-type zinc finger domains. The protein is expressed early in embryogenesis and plays a critical role as both a repressor and activator of transcription. Human GLIS3 mutations are extremely rare.en
dc.publisherEndocrine Societyen
dc.rightsArchived with thanks to The Journal of clinical endocrinology and metabolismen
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.::Geneticsen
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen
dc.titleExpanding the Clinical Spectrum Associated With GLIS3 Mutations.en
dc.typeJournal Articleen
dc.typeResearch Support, Non-U.S. Gov'ten
dc.identifier.journalThe Journal of Clinical Endocrinology and Metabolismen
dc.description.noteThis article is freely available via PubMed Central. Click on the 'Additional Link' above to access the full text.en

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record